Skip to main content
SpringerLink
Log in

Tissue inhibitor of metalloprotease (TIMP)‐1 and proliferative behaviour of clonal breast cancer cells

  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

In the present paper, we have examined whether human tissue inhibitor of metalloprotease‐1 (hTIMP‐1) is able to exert a growth factor‐like effect on two clonal cell lines (BC‐3A and BC‐61), isolated from a parental line of human breast carcinoma cells (8701‐BC), and endowed with different growth and invasive behaviour ‘in vitro’ and in nude mouse. The data obtained indicate that only the more tumorigenic clonal cell line (BC‐61) is responsive to hTIMP‐1 treatment by increasing its proliferative rate in a dose‐dependent manner. It was also found that BC‐61 cells selectively express a transmembrane protein of about 80 kDa able to bind hTIMP‐1 ‘in vitro’ and ‘in vivo’ with high affinity (Kd of 0.07 ± 0.004   nM), and that treatment of BC‐61 cells with a proliferation‐promoting concentration of hTIMP‐1 is able to stimulate tyrosine‐targeted phosphorylation. The cumulative results obtained strongly support the hypothesis that hTIMP‐1, ‘classically’ regarded as a collagenase inhibitor, may be a crucial element of the extracellular signalling network during breast cancer development by controlling cell growth phenotype in autocrine and paracrine manner, and that intratumoural heterogeneity for the biological response to TIMP‐1 may exist within the composite cell population of the primary tumour site.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Mignatti P, Rifkin DB: Biology and biochemistry of proteinases in tumour invasion. Physiol Rev 73: 161–185, 1993

    Google Scholar 

  2. Kleiner DE Jr, Stetler-Stevenson WG: Structural biochemistry and activation of matrix metalloproteases. Curr Opin Cell Biol 5: 891–897, 1993

    Google Scholar 

  3. Baramova E, Foidar J-M: Matrix metalloproteinase family. Cell Biol Intl 19: 239–242, 1995

    Google Scholar 

  4. De Clerck YA: Tissue inhibitors of metalloproteinases: Comparative analysis and role in tumor progression. Cell Biol Intl 19: 244–245, 1995

    Google Scholar 

  5. Greene J, Wang M, Liu YE, Raymond LA, Rosen C, Shi YE: Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4. J Biol Chem 271: 30375–30380, 1996

    Google Scholar 

  6. Denhardt DT, Feng B, Edwards DR, Cocuzzi ET, Malyankar UM: Tissue inhibitor of metalloproteinases (TIMP, aka EPA): Structure, control of expression and biological functions. Pharmac Ther 59: 329–341, 1993

    Google Scholar 

  7. Howard EW, Bullen EC, Banda MJ: Preferential inhibition of 72 and 92 kDa gelatinases by tissue inhibitor of metalloproteinases-2. J Biol Chem 266: 13070–13075, 1991

    Google Scholar 

  8. Bian J, Wang Y, Smith MR, Kim H, Jacobs C, Jackman J, Kung H-F, Colburn NH, Sun Y: Suppression of in vivo tumour growth and induction of suspension cell death by tissue inhibitor of metalloproteinases (TIMP)-3. Carcinogenesis 17: 1805–1811, 1996

    Google Scholar 

  9. Schultz RM, Silberman S, Persky B, Bajkowski AS, Carmichael DF: Inhibition by human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonization by murine B16-F10 melanoma cells. Cancer Res 48: 5539–5545, 1988

    Google Scholar 

  10. Yoshiji H, Gomez DE, Thorgeirsson UP: Enhanced RNA expression of tissue inhibitor of metalloproteinases-1 (TIMP-1) in human breast cancer. Int J Cancer 69: 131–134, 1996

    Google Scholar 

  11. Hansen Ree A, Flørenes VA, Berg JP, Maelandsmo GM, Nesland JM, Fodstad Ø: High levels of messenger RNAs for tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in primary breast carcinomas are associated with development of distant metastases. Clin Cancer Res 3: 1623–1628, 1997

    Google Scholar 

  12. Minafra S, Morello V, Glorioso F, La Fiura AM, Tomasino RM, Feo S, McIntosh D, Woolley DE: A new cell line (8701-BC) from primary ductal infiltrating carcinoma of human breast. Brit J Cancer 60: 185–192, 1989

    Google Scholar 

  13. Pucci-Minafra I, Minafra S, Alessandro R, Faccini AM: An ultrastructural evaluation of cell heterogeneity in invasive ductal carcinomas of the human breast II: An in vitro study. J Submicrosc Cytol Pathol 21: 488–499, 1989

    Google Scholar 

  14. Pucci-Minafra I, Minafra S, Faccini AM, Alessandro R: An ultrastructural evaluation of cell heterogeneity in invasive ductal carcinomas of the human breast I: An in vivo study. J Submicrosc Cytol Pathol 21: 475–488, 1989

    Google Scholar 

  15. Luparello C, Ginty AF, Gallagher JA, Pucci-Minafra I, Minafra S: Transforming growth factor-b1,-b2,-b3, urokinase and parathyroid hormone-related peptide expression in 8701-BC cells and clones. Differentiation 55: 73–80, 1993

    Google Scholar 

  16. Alessandro R, Minafra S, Pucci-Minafra I, Onisto M, Garbisa S, Melchiori A, Tetlow L, Woolley DE: Metalloproteinase and TIMP expression by the human breast carcinoma cell line 8701-BC. Int J Cancer 55: 250–255, 1993

    Google Scholar 

  17. Cifone MA, Fidler IH: Correlations of patterns of anchorageindependent growth with in vivo behaviour of cells from a murine fibrosarcoma. Proc Natl Acad Sci USA 77: 1039–1043, 1980

    Google Scholar 

  18. Ogata Y, Itoh Y, Nagase H: Steps involved in activation of the pro-matrix metalloproteinase 9 (progelatinase B)-tissue inhibitor of metalloproteinase-1 complex by 4-aminophenylmercuric acetate and proteinases. J Biol Chem 270: 18506–18111, 1995

    Google Scholar 

  19. Behrendt N, Rønne E, Plong M, Petri T, Løber D, Nielsen LS, Schleuning WD, Blasi F, Appella E, Danø K: The human receptor for urokinase plasminogen activator. J Biol Chem 265: 6453–6460, 1990

    Google Scholar 

  20. Minafra S, Giambelluca C, Andriolo M, Pucci-Minafra I: Cell–cell and cell–collagen interactions influence gelatinase production by human breast carcinoma cell line 8701-BC. Int J Cancer 62: 777–783, 1995

    Google Scholar 

  21. Barbieri R, Duro G, Costa MA, Izzo V: Simple and inexpensive dot-blot apparatus. Analyt Biochem 216: 461–462, 1994

    Google Scholar 

  22. Yamashita K, Suzuki M, Iwata H, Koike T, Hamaguchi M, Shinagawa A, Noguchi T, Hayakawa T: Tyrosine phosphorylation is crucial for growth signaling by tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2). FEBS Lett 396: 103–107, 1996

    Google Scholar 

  23. Shofuda K, Yasumitsu H, Nishihashi A, Miki K, Miyazaki K: Expression of three membrane-type matrix metalloproteinases (MT-MMPs) in rat vascular smooth muscle cells and characterization of MT3-MMPs with and without transmembrane domain. J Biol Chem 272: 9749–9754, 1997

    Google Scholar 

  24. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seiki M: A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370: 61–65, 1994

    Google Scholar 

  25. Docherty AJP, Lyons A, Smith BJ, Wright EM, Stephens PE, Harris TJR, Murphy G, Reynolds JJ: Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-protentiating activity. Nature 318: 66–69, 1985

    Google Scholar 

  26. Avalos BR, Kaufman SE, Tomonaga M, Williams RE, Golde DW, Gasson JC: K562 cells produce and respond to human erythroid-potentiating activity. Blood 71: 1720–1725, 1988

    Google Scholar 

  27. Bertaux B, Hornebeck W, Eisen AZ, Dubertret L: Growth stimulation of human keratinocytes by tissue inhibitor of metalloproteinases. J Invest Dermatol 97: 679–685, 1991

    Google Scholar 

  28. Hayakawa T, Yamashita K, Tanzawa K, Uchijima E, Iwata K: Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. FEBS Lett 298: 29–32, 1992

    Google Scholar 

  29. Kikuchi K, Kadono T, Furue M, Tamaki K: Tissue inhibitor of metalloproteinase 1 (TIMP-1) may be an autocrine growth factor in scleroderma fibroblasts. J Invest Dermatol 108: 281–284, 1997

    Google Scholar 

  30. Heppner GH, Miller FR: The cellular basis of tumor progression. Int Rev Cytol 177: 1–56, 1998

    Google Scholar 

  31. Luparello C, Noël A, Pucci-Minafra I: Intratumoral heterogeneity for hsp90ß mRNA levels in a breast cancer cell line. DNA Cell Biol 16: 1231–1236, 1997

    Google Scholar 

  32. Luparello C, Burtis WJ, Raue F, Birch MA, Gallagher JA: Parathyroid hormone-related peptide and 8701-BC breast cancer cell growth and invasion in vitro: Evidence for growthinhibiting and invasion-promoting effects. Mol Cell Endocrinol 111: 225–232, 1995

    Google Scholar 

  33. Luparello C, Birch MA, Gallagher JA, Burtis WJ: Clonal heterogeneity of the growth and invasive response of a human breast carcinoma cell line to parathyroid hormone-related peptide fragments. Carcinogenesis 18: 23–29, 1997

    Google Scholar 

  34. Schillaci R, Luparello C, Minafra S: Type I and I-trimer collagens as substrates for breast carcinoma cells in culture. Effect on growth rate, morphological appearance and actin organization. Eur J Cell Biol 48: 135–141, 1989

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dipartimento di Biologia Cellulare e dello Sviluppo, Università, Palermo, Italy

    Claudio Luparello, Grazia Avanzato, Cintia Carella & Ida Pucci‐Minafra

Authors
  1. Claudio Luparello
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Grazia Avanzato
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Cintia Carella
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ida Pucci‐Minafra
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Luparello, C., Avanzato, G., Carella, C. et al. Tissue inhibitor of metalloprotease (TIMP)‐1 and proliferative behaviour of clonal breast cancer cells. Breast Cancer Res Treat 54, 235–244 (1999). https://doi.org/10.1023/A:1006121129382

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006121129382

Search

Navigation